The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Legislation (81)
- (-) Non-prescription medicines (50)
- Advertising (248)
- Medicine safety (159)
- COVID-19 (144)
- Prescription medicines (138)
- Regulatory compliance (128)
- COVID-19 vaccines (88)
- Therapeutic goods regulation (75)
- Listed medicines (54)
- Safety (49)
- Medical devices safety (43)
- Vaping hub (39)
- Complementary medicines (33)
- Manufacturing (33)
- Labelling and packaging (28)
- Assessed listed medicines (26)
- Over the counter (OTC) medicines (25)
- Scheduling (national classification system) (24)
- Australian Register of Therapeutic Goods (ARTG) (22)
- Compliance and enforcement hub (22)
- Medicinal cannabis hub (21)
- Import and export (19)
- Alert/Advisory (18)
- Shortages (12)
- In Vitro Diagnostic medical devices (IVDs) (11)
- Sunscreens (8)
- Weight loss products (8)
- Advisory bodies and committees (5)
- Clinical trials (3)
- Cosmetics (3)
- Blood and blood components (2)
- Fees and payments (2)
- Prescription opioids hub (2)
- Registered complementary medicines (2)
- Unique Device Identification (UDI) hub (2)
- Advanced therapies (1)
- Biological medicines (1)
- Blood safety (1)
- Breast implant hub (1)
- Travelling with health products (1)
Search
126 result(s) found, displaying 51 to 75
-
NoticesThis instrument is made under subsection 26BD(3) of the Therapeutic Goods Act 1989.
-
Therapeutic Goods (Biologicals-Application Form for Priority Applicant Determinations) Approval 2022
NoticesApproval of the Therapeutic Goods (Biologicals—Application Form for Priority Applicant Determinations) -
NoticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 5) 2022.
-
NoticesArrangement under subsection 7C(1) of the Therapeutic Goods Act 1989 for use of computer programs to make decisions under sections 61(3)(a), 61(5AA), and 61(5AB) of the Act
-
NewsThe Pharmacovigilance Inspection Program (PVIP) Risk Assessment Survey is now open until 18 December 2022 for medicine sponsors to complete.
-
Media releasesJSHealth Vitamins Pty Ltd fined for alleged unlawful advertising
-
Media releasesThe TGA has published an independent expert report examining the incidence of serious injury and death from intentional paracetamol overdose.
-
NoticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 4) 2022.
-
NoticesThis Order revokes Therapeutic Goods (Groups) Order No. 1 of 1992.
-
NoticesThis Order may be cited as Therapeutic Goods (Groups) Order No. 1 of 1992.
-
NoticesThis Order revokes Therapeutic Goods (Groups) Order No. 1 of 1991.
-
NoticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2022.
-
Media releasesConsumers are advised to be cautious about ivermectin products that are sold by unverified online stores.
-
NoticesA new Therapeutic Goods Determination for listed medicine ingredients commences on 1 March 2022.
-
NoticesA new Therapeutic Goods Determination for listed medicine ingredients commenced on 18 January 2022.
-
NewsThe new Therapeutic Goods (Medicines Advisory Statements) Specification 2021 commences 1 January 2022
-
NoticesA new Therapeutic Goods Determination for listed medicine ingredients commenced on 25 October 2021.
-
NoticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
NoticesThe Minamata Convention facilitates a global approach to address concerns relating to mercury, which is persistent, toxic and highly mobile in the environment once released, and recognised as a substance producing significant neurological and other effects in humans.
-
NewsInformation about how sunscreens are approved for supply in Australia and what you will see on sunscreen labels.
-
NoticesThis instrument is made under subregulations 4A.2(4) of the Therapeutic Goods (Medical Devices) Regulations 2002.
-
NoticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
NoticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
NoticesArrangement under subsection 7C(1) of the Therapeutic Goods Act 1989 for use of computer programs to make decisions under sections 41FDB, 41FF and 41FH of the Act
-
NewsIn Australia, a sports supplement can be classified as either a food or a medicine